Literature DB >> 25551311

Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour.

Ellery Clugston1, Anna C Gill, Nicole Graf, Fiona Bonar, Anthony J Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25551311     DOI： 10.1097/PAT.0000000000000221

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

1.  ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.

Authors:  Shogo Tajima; Yuichi Takashi; Nobuaki Ito; Seiji Fukumoto; Masashi Fukuyama
Journal:  Med Mol Morphol       Date:  2015-06-30       Impact factor: 2.309

2.  Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.

Authors:  David A Shustik; David Ce Ng; Kesavan Sittampalam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

4.  Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors.

Authors:  Dongmei Li; Ran Zhu; Lian Zhou; Dingrong Zhong
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.